id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3517-0033,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry;
Availability",Notice,Notice of Availability,2025-01-07T05:00:00Z,2025,1,,,2025-01-07T21:44:50Z,2024-31546,0,0,09000064868a2da5
FDA-2015-D-3517-0034,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2025-01-07T05:00:00Z,2025,1,2025-01-07T05:00:00Z,,2025-02-07T02:01:17Z,,1,0,09000064868a5abc